Breaking: Moderna to Request Emergency FDA Approval for COVID Vaccine

Moderna announced on Monday morning that it would seek emergency approval for its coronavirus vaccine from the U.S. Food and Drug Administration.

The announcement came after Moderna confirmed that its vaccine is 94-percent effective against coronavirus. If approved, the Moderna vaccine could be available to certain segments of the population within two weeks. Pfizer and BioNTech also applied for emergency authorization for their jointly-developed vaccine on November 20.

“We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalizations and death," Moderna CEO Stephane Bancel said in a statement. Moderna stocks jumped 12 percent upon the announcement.

The vaccines employ technology never before used on such a wide scale, utilizing mRNA, a molecular protein messenger, to build immunity to coronavirus.

Moderna to Request Emergency FDA Approval for COVID Vaccine The announcement came after Moderna confirmed that its vaccine is 94-percent effective against ... READ MORE ADVERTISEMENT Follow Us & Share 19 West 44th Street, Suite 1701, New York, NY, 10036, USA Your Preferences | Unsubscribe | Privacy View this e-mail in your browser.